Eric Crombez

Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study

Friedrich K. Trefz, Barbara K. Burton, Nicola Longo et al. · The Journal of Pediatrics · 2009 · 190 citations

Sapropterin Dihydrochloride, Medicine, Inherited Metabolic Disease +6

Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria

Phillip Lee, Eileen P. Treacy, Eric Crombez et al. · American Journal of Medical Genetics Part A · 2008 · 101 citations

Sapropterin Dihydrochloride, Metabolic Disorder, Pharmacotherapy +16

Expanded newborn screening identifies maternal primary carnitine deficiency

Lisa A. Schimmenti, Eric Crombez, Bernd Schwahn et al. · Molecular Genetics and Metabolism · 2006 · 92 citations

Nutrition, Newborn Screening, Infant Nutrition +9

Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study

Derlis Gonzalez, Hadhami Ben Turkia, Elena Lukina et al. · American Journal of Hematology · 2012 · 84 citations · Full text

Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease

Hadhami Ben Turkia, Derlis Gonzalez, Norman W. Barton et al. · American Journal of Hematology · 2012 · 70 citations · Full text

Immunohematology, Gaucher Disease, Enzyme Replacement Therapy +8